Clincosm LogoSign in Get a demo

crohn disease

Showing 1 - 25 of 591
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

Not yet recruiting
  • Crohn Disease
  • +4 more
  • TDM-based infliximab intravenous therapy
  • Standard infliximab intravenous therapy
  • (no location specified)
Sep 22, 2023

Diverse Ancestry Study in IBD

Recruiting
  • Ulcerative Colitis
  • +3 more
  • Blood or saliva sample collection
  • Toronto, Ontario, Canada
    Sinai Health System
Sep 13, 2023

Endoscopic Treatment of Stenosis in Crohn´s Disease

Active, not recruiting
  • Crohn Disease
  • Stenosis
    • Terrassa, Barcelona, Spain
      Hospital Universitari Mutua Terrassa
    Sep 12, 2023

    IBD, Ulcerative Colitis, Crohn Disease Trial (Biologic Care Pathway)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • Biologic Care Pathway
    • (no location specified)
    Sep 2, 2023

    IBD, IBD, Crohn Disease Trial in Cincinnati (SMART-IBD)

    Recruiting
    • Inflammatory Bowel Diseases
    • +3 more
    • SMART-IBD
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Sep 1, 2023

    Irritable Bowel Syndrome, IBD, Crohn Disease Trial in Maastricht (ESM and Traqq)

    Recruiting
    • Irritable Bowel Syndrome
    • +5 more
    • ESM and Traqq
    • Maastricht, Limburg, Netherlands
      Maastricht UMC+
    Aug 11, 2023

    IBD, Crohn Disease, Ulcerative Colitis Trial in Moscow (Telemedical intervention)

    Enrolling by invitation
    • Inflammatory Bowel Diseases
    • +2 more
    • Telemedical intervention
    • Moscow, Russian Federation
      Research and Practical Clinical Center for Diagnostics and Telem
    Aug 8, 2023

    Crohn Disease Trial in Besançon (Kono-S anastomosis, Conventional anastomosis for ileocolonicresection of Crohn's disease)

    Not yet recruiting
    • Crohn Disease
    • Kono-S anastomosis
    • Conventional anastomosis for ileocolonicresection of Crohn's disease
    • Besançon, France
      CHu de Besançon
    Jul 26, 2023

    Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells

    Not yet recruiting
    • Crohn Disease
    • Anal Fistula
    • (no location specified)
    Jul 26, 2023

    Crohn Disease Trial (Freeze dried grape powder)

    Not yet recruiting
    • Crohn Disease
    • Freeze dried grape powder
    • (no location specified)
    Aug 1, 2023

    Insomnia, Crohn Disease Trial in Lebanon (Behavioral Treatment, Sleep Education Treatment)

    Not yet recruiting
    • Insomnia
    • Crohn Disease
    • Behavioral Treatment
    • Sleep Education Treatment
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Jul 13, 2023

    Bowel Sounds, Intestinal Inflammation, Crohn Disease Trial in Amiens (Abdominal auscultation)

    Active, not recruiting
    • Bowel Sounds
    • +2 more
    • Abdominal auscultation
    • Amiens, France
      CHU Amiens
    Jul 13, 2023

    Crohn Disease Trial in Leuven (midfulness training)

    Not yet recruiting
    • Crohn Disease
    • midfulness training
    • Leuven, Belgium
      University Hospitals Leuven
    Jul 10, 2023

    Crohn Disease Trial in Santiago de Compostela (MBF-018 oral capsules)

    Recruiting
    • Crohn Disease
    • MBF-018 oral capsules
    • Santiago de Compostela, Galicia, Spain
      Hospital Clínico Universitario de Santiago de Compostela
    Jul 7, 2023

    Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

    Not yet recruiting
    • Crohn Disease
    • TNFa Antagonist - Infliximab
    • +5 more
    • Calgary, Alberta, Canada
      University of Calgary
    Jun 22, 2023

    Tolerability of Methotrexate in Inflammatory Bowel Disease

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • +2 more
      • Vandoeuvre Les Nancy, Grand Est, France
        CHRU of Nancy
      Jun 23, 2023

      IBD, Crohn Disease, Ulcerative Colitis Trial in Orléans (Blood and fecal samples, Coolonic biopsies)

      Recruiting
      • Inflammatory Bowel Diseases
      • +2 more
      • Blood and fecal samples
      • Coolonic biopsies
      • Orléans, France
        CHR Orléans
      Jun 14, 2023

      Patients Switching FromLow To High Concentration Adalimumab

      Recruiting
      • Crohn Disease
      • +6 more
      • AVT02 (Alvotech Biosimilar to Adalimumab)
      • Montréal, Quebec, Canada
        JAMP Pharma Corporation
      Jun 13, 2023

      Crohn Disease Trial in Beijing (Infliximab)

      Not yet recruiting
      • Crohn Disease
      • Beijing, China
        Beijing Children's Hospital, Capital Medical University
      Jun 13, 2023

      Crohn Disease Trial (RVT-3101)

      Not yet recruiting
      • Crohn Disease
      • (no location specified)
      Jun 9, 2023

      TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)

      Not yet recruiting
      • Crohn Disease
      • Magnetic Resonance Enterography (MRE)
      • Liège, Belgium
      • +17 more
      Jun 5, 2023

      Mesenteric Bacterial Translocation in Evolved Crohn's Disease

      Recruiting
      • Crohn Disease
        • Terrassa, Barcelona, Spain
          Hospital Universitari MútuaTerrassa
        May 26, 2023

        Remote Monitoring of IBD

        Recruiting
        • Inflammatory Bowel Diseases
        • +2 more
        • patient reported outcome measures
        • +2 more
        • Den Bosch, Netherlands
        • +4 more
        May 23, 2023

        Upper Gastrointestinal Tract of Crohn's Disease

        Completed
        • Crohn Disease
        • General variables
        • +3 more
        • Terrassa, Barcelona, Spain
          Hospital Universitari Mutua Terrassa
        May 23, 2023

        Crohn Disease Trial (selective intensive induction therapy based on ustekinumab clinical decision-making tools)

        Not yet recruiting
        • Crohn Disease
        • selective intensive induction therapy based on ustekinumab clinical decision-making tools
        • (no location specified)
        May 6, 2023